OraScan 1 percent toluidine blue data

University researchers published in the Journal of Oral Pathology and Medicine results of a study in 102 patients with oral squamous cell carcinomas. Patients were first examined by two oral cancer specialists; the OraScan rinse was then administered. All 11 clinically suspected carcinomas and 7 other unsuspected cancers confirmed by histopathology were stain-positive. There were no false-negative results. ...